Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure-Reference-Cited by-同舟云学术

Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure

Published:2012-01 Issue:1 Volume:14 Page:14-21
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Gomez Nelson¹,Touihri Karim¹,Matheeussen Veerle²,Da Costa Agnès Mendes¹,Mahmoudabady Maryam¹³,Mathieu Myrielle¹,Baerts Lesley²,Peace Aaron⁴,Lybaert Pascale⁵,Scharpé Simon²,De Meester Ingrid²,Bartunek Jozef⁴,Vanderheyden Marc⁴,McEntee Kathleen¹

Affiliation:

1. Laboratory of Physiology; Faculty of Medicine, ULB; Brussels Belgium

2. Laboratory of Medical Biochemistry; Faculty of Pharmaceutical, Biomedical and Veterinary Sciences; UA Antwerp Belgium

3. Department of Physiology; Mashhad University of Medical Sciences; Mashhad Iran

4. Cardiovascular Center; Onze Lieve Vrouw Ziekenhuis; Aalst Belgium

5. Laboratory of Experimental Hormonology; Faculty of Medicine, ULB; Brussels Belgium

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfr146/fullpdf

Reference39 articles.

1. State of the art: using natriuretic peptide levels in clinical practice;Maisel;Eur J Heart Fail,2008

2. The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failure;Lourenço;Eur J Heart Fail,2009

3. Corin gene expression is inversely related to increased BNP expression in advanced cardiomyopathy: setting the stage for inefficient natriuretic peptide processing in heart failure;Dries;Circulation,2005

4. The role of neutral endopeptidase in dogs with evolving congestive heart failure;Margulies;Circulation,1995

5. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form;Brandt;Clin Chem,2006

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review;Tetrahedron;2024-08

2. Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia;PLOS ONE;2024-07-29

3. DPP‐4 inhibitor sitagliptin treatment results in altered myocardial metabolic proteome and oxidative phosphorylation in a swine model of chronic myocardial ischemia;Physiological Reports;2024-03

4. Environmentally friendly protocol for the determination of sitagliptin phosphate in pharmaceutical preparations and biological fluids using l‐tyrosine as a fluorescence probe;Luminescence;2023-08-21

5. Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus;Diabetes Research and Clinical Practice;2023-08